Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Claritas Pharmaceuticals Inc V.CLAS.H

Alternate Symbol(s):  CLAZF

Claritas Pharmaceuticals, Inc., formerly Kalytera Therapeutics Inc, is a biotechnology company that is focused on developing R-107 for the treatment of vaccine-resistant coronavirus disease (COVID) strains. The Company’s products in development include R-107 for coronavirus disease and Viral Infections, R-107 and Vaccines, and CLA-1816 for treatment of pain. R-107 is designed to defeat COVID viruses on contact. R-107 targets the Achilles heel of COVID, the spike protein on the surface of the virus. R-107 releases nitric oxide, which attaches to a specific amino acid on the spike protein, thereby disabling the spike protein. The CLA-1816 provides effective pain reduction, without the risks of addiction or respiratory suppression that exist with opioid analgesics. CLA-1816 strongly binds with and activates the alpha3 glycine pain receptor in the spine. The Company has leased a laboratory, office, and archival space in Beverly, Massachusetts.


TSXV:CLAS.H - Post by User

Post by mavericks2020on May 09, 2021 10:07am
299 Views
Post# 33161600

4000 death in one second

4000 death in one second
The company save the planet is Claritas Pharmaceutical.The vaccination dont enoufh rapidly as variant May 9, 2021
8:00 AM EDT
India
India turns to ex-army medics as COVID surge sparks calls for lockdown
Abhirup RoyAishwarya Nair
 
 
 
 
1 minute read
Medical workers tend to a patient suffering from coronavirus disease (COVID-19), as a Syringe Infusion Pump, donated by France is seen next to his bed, inside the emergency room of Safdarjung Hospital in New Delhi, India, May 7, 2021. REUTERS/Adnan Abidi
Relatives react as healthcare workers pull a stretcher carrying the body of a person who died from the coronavirus disease (COVID-19), at a mortuary in Ahmedabad, India, May 8, 2021. REUTERS/Amit Dave
A woman mourns after her husband died due to the coronavirus disease (COVID-19) outside a mortuary of a COVID-19 hospital in Ahmedabad, India, May 8, 2021. REUTERS/Amit Dave
 
 
1/5
Relatives react as healthcare workers pull a stretcher carrying the body of a person who died from the coronavirus disease (COVID-19), at a mortuary in Ahmedabad, India, May 8, 2021. REUTERS/Amit Dave
 
 
India is to recruit hundreds of former army medics to support its overwhelmed healthcare system, the defence ministry said on Sunday, as the country grapples with record COVID-19 infections and deaths amid angry calls for a complete nationwide lockdown.
 
Some 400 medical officers are expected to serve on contract for a maximum of 11 months, the ministry said in a press release, adding that other defence doctors had also been roped in for online consultations.
 
COVID-19 cases and deaths have been hitting records every two or three days. Deaths rose by more than 4,000 for a second consecutive day on Sunday.
 
Many Indian states have imposed strict lockdowns over the past month while others have announced restrictions on public movement and shut down cinemas, restaurants, pubs and shopping malls.
 
But pressure is mounting on Prime Minister Narendra Modi to announce a nationwide lockdown as it did during the first wave last year.
 
The Indian Medical Association (IMA) called for a "complete, well-planned, pre-announced" lockdown instead of "sporadic" night curfews and restrictions imposed by states for a few days at a time.
 
"IMA is astonished to see the extreme lethargy and inappropriate actions from the ministry of health in combating the agonizing crisis born out of the devastating second wave of the COVID-19 pandemic," it said in a statement on Saturday.
 
Modi is battling criticism for allowing huge gatherings at a religious festival and holding large election rallies over the past two months even as COVID-19 cases were surging.
 
The health ministry reported 4,092 deaths over the past 24 hours, taking the overall death toll to 242,362. New cases rose by 403,738, just shy of the record and increasing the total since the start of the pandemic to 22.3 million.
 
India on Saturday reported its highest ever single-day COVID-19 death toll of 4,187. The Institute for Health Metrics and Evaluation estimates that India will see 1 million COVID-19 deaths by August. read more
 
With an acute shortage of oxygen and beds in many hospitals and with morgues and crematoriums overflowing, experts have said the actual numbers for COVID-19 cases and fatalities could be far higher than reported.
 
The world's largest vaccine producing nation has fully vaccinated just over 34.3 million, or only 2.5%, of its 1.35 billion population as of Sunday, according to data from the government's Co-WIN portal.
 
Support has been pouring in from around the world in the form of oxygen cylinders and concentrators, ventilators and other medical equipment.
 
Our Standards: The Thomson Reuters Trust Principles.

<< Previous
Bullboard Posts
Next >>